Michael Tusche: Biotech Leadership, Wall Street Investment & AI-Driven Drug Development

In this Episode, our guest is Dr. Michael Tusche, Ph.D., M.B.A, a visionary biotech leader and seasoned investor in the space. Dr. Tusche is also the CEO of 3io Therapeutics, a biotechnology company focused on the development and commercialization of the next generation of viral immunotherapies for cancer. Dr. Tusche is also the Co-Founder and current Board Director at Nirsum Labs, a biotechnology company inventing and developing new medications for opioid use disorder (OUD). We discuss how Michael began his career, from his academia spanning a number of years at the University of Victoria as well as the University of Toronto, to then moving into industry. We then move into a discussion on investing into biotechs, and Dr. Tusche provides insight on how to become a successful biotech leader, with interesting stories and optimisation tips.Dr. Tusche reveals an amazing blend of experiences and advice, featuring discussions of early investment, oncology, micromanagement, addiction, ChatGPT, and obesity. This conversation applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership. Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentDr. Micheal TuscheLinkedIn: https://www.linkedin.com/in/vcbiotechceo/Lawrence RoseCo-Founder + Talent Solutions Director At ARTOLinkedIn: https://www.linkedin.com/in/lawrencerose/Timestamps:00:00 Career Beginnings08:12 Investing In & Leading Biotech Companies14:44 Differentiators in Biotech Success24:42 Trends in Biotechs36:45 Building Optimised Teams in Biotechs45:06 Quick-fire Round#LeadingBeyondTheLab #ARTOTalent #Biotechnology #Oncology Hosted on Acast. See acast.com/privacy for more information.